Behavioural assessment of mice lacking D(1A) dopamine receptors

Neuroscience

Volumn 86, Issue 1, 1998, Pages 135-146

  Smith, D R ^a   Striplin, C D ^b   Geller, A M ^c   Mailman, R B ^b   Drago, J ^d   Lawler, C P ^b   Gallagher, M ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^d MONASH UNIVERSITY   (Australia)

Author keywords

D(1A) dopamine receptor; Knockout; Locomotion; Morris water maze; Sensorimotor; Transgenic mice

Indexed keywords

DOPAMINE 1 RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; GENE SEQUENCE; GENE TARGETING; KNOCKOUT MOUSE; LOCOMOTION; MAZE TEST; MOUSE; NONHUMAN; ORIENTING RESPONSE; PRIORITY JOURNAL; STIMULUS RESPONSE; TASK PERFORMANCE; TRANSGENIC MOUSE;

ANIMALS; ASSOCIATION LEARNING; CROSSES, GENETIC; CUES; DISCRIMINATION (PSYCHOLOGY); EVOKED POTENTIALS, VISUAL; EXPLORATORY BEHAVIOR; FEMALE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; ORIENTATION; RECEPTORS, DOPAMINE D1; SMELL;

EID: 0031842043     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00608-8     Document Type: Article

References (62)

1. Accilli D., Fishburn C. S., Drago J., Steiner H., Lachowicz J. E., Park B.-E., Gauda E. B., Lee E. J., Cool M. H., Sibley D. R., Gerfen C. R., Westphal H. and Fuchs S. (1993) A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc. natn. Acad. Sci. U.S.A. 3, 1945-1949.
2. 1 receptor agonist A-77636 increases cortical and hippocampal acetylcholine release in the rat. Eur. J. Pharmac. 260, 85-87.
3. 2 classification. Trends pharmac. Sci. 11, 231-236.
4. 2 receptors differentially inhibits stereotypies induced by dopamine agonists in rats. Eur. J. Pharmac. 155, 37-47.
5. 2 receptors. Nature 377, 424-428.
6. 5 dopamine receptors in primate brain. J. Neurosci. 15, 7821-7836.
7. Calcagnetti D. J. and Schechter M. D. (1993) Place preference for the psychostimulant cathinone is blocked by pretreatment with a dopamine release inhibitor. Prog. Neuropsychopharmac. biol. Psychiat. 17, 637-649.
8. Camper S. A., Saunders T. L., Kendall S. K., Keri R. A., Seasholtz A. F., Gordon D. F., Birkmeier T. S., Keegan C. E., Karolyi I. J. and Roller M. L. (1995) Implementing transgenic and embryonic stem cell technology to study gene expression, cell-cell interactions and gene function. Biol. Reprod. 52, 246-257.
9. Chrobak J. J. and Napier T. C. (1992) Delayed non-match-to-sample performance in the radial arm maze: effects of dopaminergic and GABAergic agents. Psychopharmacology 108, 72-78.
10. Costall B., Fortune D. H., Hui S.-C. and Naylor R. J. (1980) Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the nucleus accumbens: drug interaction at presynaptic receptors? Eur. J. Pharmac. 63, 347-358.
11. Crabbe J. C. (1986) Genetic differences in locomotor activation in mice. Pharmac. Biochem. Behav. 25, 289-292.
12. Crooke S. T. and Bennett C. F. (1996) Progress in antisense oligonucleotide therapeutics. A. Rev. Pharmac. Toxicol. 36, 107-129.
13. Day J. C. and Fibiger H. C. (1994) Dopaminergic regulation of septohippocampal cholinergic neurons. J. Neurochem. 63, 2086-2092.
14. 1 dopamine receptors in human putamen, frontal cortex and calf retina: differences in guanine nucleotide regulation of agonist binding and adenylate cyclase stimulation. Brain Res. 443, 77-84.
15. 1A dopamine receptors. Proc. natn. Acad. Sci. U.S.A. 91, 12564-12568.
16. 2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats. Brain Res. 487, 267-277.
17. Gasbarri A., Sulli A., Innocenzi R., Pacitti C. and Brioni J. D. (1996) Spatial memory impairment induced by lesion of the mesohippocampal dopaminergic system in the rat. Neuroscience 74, 1037-1044.
18. Gatley S. J., Meehan S. M., Chen R., Pan D. F. and Schechter M. D. (1996) Place preference and microdialysis studies with two derivatives of methylphenidate. Life Sci. 58, PL345-PL352.
19. Geller A. M., Osborne C. M. and Peiffer R. L. (1995). The erg, eog, and vep in rats. In Ocular Toxicology (ed. Weisse I.), pp. 7-25. Plenum, New York.
20. Gerfen C. R. (1995) Dopamine receptor function in the basal ganglia. Clin. Neuropharmac. 18, S162-S167.
21. Gerlai R. (1996) Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? Trends Neurosci. 5, 177-189.
22. Gingrich J. A. and Caron M. G. (1993) Recent advances in the molecular biology of dopamine receptors. A. Rev. Neurosci. 16, 299-321.
23. Giros B., Jaber M., Jones S. R., Wightman R. M. and Caron M. G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612.
24. Grandy D. K. and Civelli O. (1992) G-protein-coupled receptors: the new dopamine receptor subtypes. Curr. Opin. Neurobiol. 2, 275-281.
25. 1-receptors in morphine-induced hyperlocomotion in mice. Neurosci. Lett. 169, 1-4.
26. Herr D. W. and Boyes W. K. (1995). Electrophysiological analysis of complex brain systems: sensory-evoked potentials and their generators. In Neurotoxicology: Approaches and Methods (eds Chang L. W. and Slikker W. Jr.), pp. 205-221. Academic, New York.
27. 1 receptor ligands modulate cognitive performance and hippocampal acetylcholine release in memory-impaired aged rats. Neuroscience 69, 1067-1074.
28. 3H) dopamine: distribution, regulation and relationship to coupling. Neuroscience 46, 687-700.
29. 1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro. Molec. Pharmac. 31, 50-57.
30. Jackson D. M., Anden N.-E. and Dahl-Strom A. (1975) A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich parts of the rat brain. Psychopharmacology 45, 139-149.
31. Kappel C. A., Bieberich C. J. and Jay G. (1994) Evolving concepts in molecular pathology. Fedn Am. Socs exp. Biol. J. 8, 583-592.
32. Kappel C. A., Zhang S. X., Bieberich C. J. and Jay G. (1992) Regulating gene expression in transgenic animals. Curr. Opin. Biotech. 3, 548-553.
33. Kilts C. D., Anderson C. M., Ely T. D. and Mailman R. B. (1988) The biochemistry and pharmacology of mesoamygdaloid dopamine neurons. Ann. N. Y. Acad Sci. 537, 173-187.
34. Koretsky A. P. (1992) Investigation of cell physiology in the animal using transgenic technology. Am. J. Physiol. 262, C261-C275.
35. 3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding. Eur. J. Neurosci. 5, 145-153.
36. 2 dopamine receptors: visualization of cellular expression patterns in motor and limbic structures. Synapse 20, 325-337.
37. Lhotellier L., Perez-Diaz F. and Cohen-Salmon C. (1993) Locomotor and exploratory activity in three inbred strains of mice from young adulthood to senescence. Expl Aging Res. 19, 177-187.
38. 1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques. Neuroscience 46, 959-971.
39. 5 dopamine receptor mRNA in rat brain. Neurosci. Lett. 145, 209-212.
40. 1 agonist SK&F 38393 in rats. Synapse 13, 310-314.
41. 1 receptor deficient mice. NeuroReport 6, 2314-2316.
42. Montague D. M., Overcash J. S., Striplin C. D., Drago J., Mailman R. B. and Lawler C. P. (1996) D1A receptor-deficient transgenic mice reveal D1B (D5) receptors in hippocampus. Soc. Neurosci. Abstr. 22, 827.
43. Nestler E. J. (1994) Hard target: understanding dopaminergic neurotransmission. Cell 79, 923-926.
44. Ogawa S. and Pfaff D. W. (1996) Application of antisense DNA method for the study of molecular bases of brain function and behavior. Behav. Genet. 26, 279-292.
45. Packard M. G. and White N. M. (1991) Dissociation of hippocampus and caudate nucleus memory systems by posttraining intracerebral injection of dopamine agonists. Behav. Neurosci. 105, 295-306.
46. Pijnenburg A. J. J. and Van Rossum J. M. (1973) Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens. J. Pharm. Pharmac. 25, 1003-1004.
47. Ploeger G. E., Spruijt B. M. and Cools A. R. (1994) Spatial localization in the Morris water maze in rats: acquisition is affected by intra-accumbens injections of the dopaminergic antagonist haloperidol. Behav. Neurosci. 108, 927-934.
48. Radhakishun F. S. and Ree J. M. (1987) The hypomotility elicited by small doses of apomorphine seems exclusively mediated by dopaminergic systems in the nucleus accumbens. Eur. J. Pharmac. 136, 41-47.
49. 1 receptors. Pharmac. Biochem. Behav. 34, 895-897.
50. Scanlon K. J., Ohta Y., Ishida H., Kijima H., Ohkawa T., Kaminski A., Tsai J., Horng G. and Kashani-Sabet M. (1995) Oligonucleotide-mediated modulation of mammalian gene expression. Fedn Am. Socs exp. Biol. J. 9, 1288-1296.
51. 2 receptors: characterized by binding or pharmacological studies and physiological functions. Cell. molec. Neurobiol. 10, 303-325.
52. Sibley D. R. and Monsma F. J. Jr. (1992) Molecular biology of dopamine receptors. Trends pharmac. Sci. 13, 61-69.
53. 1/J mice. Brain Res. Bull. 32, 57-63.
54. Strange P. (1993) New insights into dopamine receptors in the central nervous system. Neurochem. Int. 22, 223-236.
55. Van Hartesveldt C., Cottrell G. A., Potter T. and Meyer M. E. (1992) Effects of intracerebral quinpirole on locomotion in rats. Eur. J. Pharmac. 214, 27-32.
56. Whishaw I. Q., Mittleman G., Bunch S. T. and Dunnett S. B. (1987) Impairments in the acquisition, retention and selection of spatial navigation strategies after medial caudate-putamen lesions in rats. Behav. Brain Res. 24, 125-138.
57. White N. M. and Hiroi N. (1992) Pipradol conditioned place preference is blocked by SCH 23390. Pharmac. Biochem. Behav. 43, 377-380.
58. 2 agonists injected peripherally or into the nucleus accumbens. Psychopharmacology 103, 271-276.
59. Wu M. and Brudzynski S. M. (1995) Mesolimbic dopamine terminals and locomotor activity induced from the subiculum. NeuroReport 6, 1601-1604.
60. 1 receptor mutant mice. Cell 79, 945-955.
61. 1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 79, 729-742.
62. Yurek D. M. and Hipkens S. B. (1993) Intranigral injections of SCH 23390 inhibit amphetamine-induced rotational behavior. Brain Res. 623, 56-64.